Product Description: TPU-0037C is a metabolite of the marine actinomycete S. platensis that is structurally similar to Lydicamycin (HY-125414). It is active against Gram-positive bacteria (MICs=0.39-3.13 μg/mL), including methicillin-resistant S. aureus strains (MIC=3.13 μg/mL), but is ineffective against Gram-negative bacteria (MICs=>50 μg/mL).
Applications: COVID-19-immunoregulation
Formula: C46H72N4O9
References: [1]Furumai, et al. TPU-0037-A, B, C and D, novel lydicamycin congeners with anti-MRSA activity from Streptomyces platensis TP-A0598. J. Antibiot. (Tokyo) 55(10), 873-880 (2002).
CAS Number: 485815-61-0
Molecular Weight: 825.09
Research Area: Infection
Target: Endogenous Metabolite